101 related articles for article (PubMed ID: 1803510)
1. Fibrinolytic activity in patients with diabetes mellitus: characterization of the effects of thrombolytic agents on plasma clot lysis in vitro.
Fears R; Standring R; Abraham R
Semin Thromb Hemost; 1991 Oct; 17(4):407-11. PubMed ID: 1803510
[No Abstract] [Full Text] [Related]
2. Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy).
Madsen MM; Busk M; Søndergaard HM; Bøttcher M; Mortensen LS; Andersen HR; Nielsen TT;
Am J Cardiol; 2005 Dec; 96(11):1469-75. PubMed ID: 16310424
[TBL] [Abstract][Full Text] [Related]
3. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
Undas A; Brozek J; Jankowski M; Siudak Z; Szczeklik A; Jakubowski H
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1397-404. PubMed ID: 16574890
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolytic enhancement by stanozolol: a double blind trial.
Davidson JF; Lochhead M; McDonald GA; McNicol GP
Br J Haematol; 1972 May; 22(5):543-59. PubMed ID: 4555715
[No Abstract] [Full Text] [Related]
5. Fibrinolysis in diabetes mellitus. Role of overweight and hypertriglyceridemia.
Cucuianu M; Fekete T; Marcusiu C; Mösler R; Duţu A
Med Interne; 1984; 22(3):171-7. PubMed ID: 6494764
[TBL] [Abstract][Full Text] [Related]
6. [Study of the fibrinolytic activity and platelet function during the 1st stage of hemostasis in diabetics].
Abastado M; Doumenc J; Prost R; Bara L; Amama M; Dérot M; Bousser J
Presse Med (1893); 1968 Jun; 76(27):1317-20. PubMed ID: 5723177
[No Abstract] [Full Text] [Related]
7. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
8. [Diabetes mellitus and fibrinolysis (experience with an in vitro clot lysis test)].
Udvardy M; Pósán E
Orv Hetil; 1994 Sep; 135(37):2025-7. PubMed ID: 7936609
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic activity in Nigerian diabetics with renal insufficiency.
Unuigbe EI; Famodu AA; Umunna CE
Clin Hemorheol Microcirc; 2005; 32(1):13-7. PubMed ID: 15665422
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological aspects of fibrinolysis].
Prino G; Mantovani M
Boll Chim Farm; 1969 Dec; 108(12):727-60 passimf. PubMed ID: 4911753
[No Abstract] [Full Text] [Related]
11. Factors contributing to the emergence of coronary thrombolysis.
Tiefenbrunn AJ; Sobel BE
Cardiol Clin; 1987 Feb; 5(1):49-53. PubMed ID: 3103920
[TBL] [Abstract][Full Text] [Related]
12. Antifibrin action of phenformin.
Banerjee RN; Kumar V; Rao SR; Sahni AL; Arya M; Bardhan J
Diabetologia; 1975 Apr; 11(2):105-11. PubMed ID: 1149944
[TBL] [Abstract][Full Text] [Related]
13. [Which laboratory parameters are useful and necessary in fibrinolytic therapy?].
Theiss W
Klin Wochenschr; 1988; 66 Suppl 12():55-8. PubMed ID: 3347008
[TBL] [Abstract][Full Text] [Related]
14. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
[TBL] [Abstract][Full Text] [Related]
15. Management of acute myocardial infarction in the public sector in the Bahamas.
Khetan S; Maharaj R; Davis GK
West Indian Med J; 2000 Jun; 49(2):115-7. PubMed ID: 10948848
[TBL] [Abstract][Full Text] [Related]
16. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic activity in diabetics before and after chlorpropamide therapy.
Mehrotra TN; Mital HS; Mishra SD; Singh VS; Kumar M
J Assoc Physicians India; 1978 May; 26(5):375-8. PubMed ID: 730717
[No Abstract] [Full Text] [Related]
18. Prehospital Fibrinolysis in concert with rapid PCI. Clinical trial shows promising results for use of clot-dissolving agents in the field.
Persse DE; McCarthy JJ; Vooletich M; Richter BK; Anderson HV; Denktas AE; Sdringola SM; Smalling RW
JEMS; 2008 Mar; 33(3):74-88. PubMed ID: 18328399
[No Abstract] [Full Text] [Related]
19. Effect of standard heparin and a low molecular weight heparin on thrombolytic and fibrinolytic activity of single-chain urokinase plasminogen activator in vitro.
Lourenço DM; Dosne AM; Kher A; Samama M
Thromb Haemost; 1989 Nov; 62(3):923-6. PubMed ID: 2556812
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.
Norhammar A; Malmberg K; Diderholm E; Lagerqvist B; Lindahl B; Rydén L; Wallentin L
J Am Coll Cardiol; 2004 Feb; 43(4):585-91. PubMed ID: 14975468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
